Anti-IP3 receptor (phospho S1598) antibody (ab111615)
Key features and details
- Rabbit polyclonal to IP3 receptor (phospho S1598)
- Suitable for: IHC-P, ICC/IF
- Reacts with: Human
- Isotype: IgG
Overview
-
Product name
Anti-IP3 receptor (phospho S1598) antibody
See all IP3 receptor primary antibodies -
Description
Rabbit polyclonal to IP3 receptor (phospho S1598) -
Host species
Rabbit -
Specificity
ab111615 detects endogenous levels of TPR1 only when phosphorylated at serine 1598(human)/1588(mouse). -
Tested applications
Suitable for: IHC-P, ICC/IFmore details -
Species reactivity
Reacts with: Human
Predicted to work with: Mouse, Rat
-
Immunogen
Synthetic phosphopeptide derived from Human ITPR1 around the phosphorylation site of serine 1598/1588 (R-D-SP-V-L).
-
Positive control
- A549 cells; Human cervix carcinoma tissue.
-
General notes
This antibody showed negative results in Western Blot
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C. -
Storage buffer
pH: 7.40
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
PBS (without Mg2+ and Ca2+) -
Concentration information loading... -
Purity
Immunogen affinity purified -
Purification notes
ab111615 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Images
-
Immunocytochemistry/ Immunofluorescence - Anti-IP3 receptor (phospho S1598) antibody (ab111615)ab111615 at 1/100 dilution staining ITPR1 in A549 cells by Immunofluorescence. The picture on the right is treated with the synthesized phosphopeptide.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IP3 receptor (phospho S1598) antibody (ab111615)ab111615 at 1/50 dilution staining ITPR1 in paraffin-embedded Human Cervix tissue by Immunohistochemistry. The image on the right is treated with the synthesized phosphopeptide.
